Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39282897

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2025 Jan 2
First author
Wolchok JD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Mar 27;392(12):1245-1246. doi: 10.1056/NEJMc2501311.
    note
    Source null
    related pmid
    40138567
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Mar 27;392(12):1246. doi: 10.1056/NEJMc2501311.
    note
    Source null
    related pmid
    40138568
    relationship
    Comment in

Authors and identifiers

  1. name
    Wolchok JD
    type
    Author
  2. name
    Chiarion-Sileni V
    type
    Author
  3. name
    Rutkowski P
    type
    Author
  4. name
    Cowey CL
    type
    Author
  5. name
    Schadendorf D
    type
    Author
  6. name
    Wagstaff J
    type
    Author
  7. name
    Queirolo P
    type
    Author
  8. name
    Dummer R
    type
    Author
  9. name
    Butler MO
    type
    Author
  10. name
    Hill AG
    type
    Author
  11. name
    Postow MA
    type
    Author
  12. name
    Gaudy-Marqueste C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wolchok JD
    type
    Author
  2. name
    Chiarion-Sileni V
    type
    Author
  3. name
    Rutkowski P
    type
    Author
  4. name
    Cowey CL
    type
    Author
  5. name
    Schadendorf D
    type
    Author
  6. name
    Wagstaff J
    type
    Author
  7. name
    Queirolo P
    type
    Author
  8. name
    Dummer R
    type
    Author
  9. name
    Butler MO
    type
    Author
  10. name
    Hill AG
    type
    Author
  11. name
    Postow MA
    type
    Author
  12. name
    Gaudy-Marqueste C
    type
    Author
bibliography ids
  1. nci-bib-667767f64cc71ae01f1848fb
book metadata
content sha256
573fd6e2aed48e00a5da421bae8dad4221af2e2f373d5f98989eecccd69bcfa7
document type
citation
dois
  1. 10.1056/NEJMoa2407417
electronic publication date
display
2024 Sep 15
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:39282897
immutable id
pubmed:39282897@573fd6e2aed48e00a5da421bae8dad4221af2e2f373d5f98989eecccd69bcfa7
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
1
name
The New England journal of medicine
nlm unique id
0255562
pages
11-22
volume
392
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Mar 27;392(12):1245-1246. doi: 10.1056/NEJMc2501311.
    note
    Source null
    related pmid
    40138567
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Mar 27;392(12):1246. doi: 10.1056/NEJMc2501311.
    note
    Source null
    related pmid
    40138568
    relationship
    Comment in
outcomes validated
false
pmid
39282897
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
4abfbc09deca020048c2dceb51210347d25bf2fcbca39310486c2551ff89b023
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 Jan 2
precision
day
year
2025
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Multicenter Study
  4. Clinical Trial, Phase III
  5. Comparative Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39282897/
title
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.

Preserved source evidence · Not medical advice